Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Rabeprazole and its saltsF1 I JUL / 03
Rabies immune globulin I FEB / 02
Rabies vaccine I FEB / 02
Racemethionine II SEP / 98
RacemethorphanN I JUN / 02
RacemoramideN I JUN / 02
RacemorphanN I JUN / 02
Raloxifene and its saltsF1 I SEP / 99
Raltegravir and its saltsF1 I MAY / 09
Raltitrexed and its salts and derivativesF1 I SEP / 98
Ramipril and its salts and derivativesF1 I SEP / 98
RamucirumabPDL I OCT / 15
RanibizumabF1 I SEP / 08
Ranitidine or its saltsPDL

except when sold in concentrations of 150 mg or less per oral dosage unit and indicated for the treatment of heartburn

I DEC / 13
Ranitidine or its salts. when sold in concentrations of 150 mg or less per oral dosage unit and indicated for the treatment of heartburn, in package sizes containing more than 4,500 mg of ranitidine III MAR / 08
Ranitidine or its salts.. when sold in concentrations of 150 mg or less per oral dosage unit and indicated for the treatment of heartburn, in package sizes containing no more than 4,500 mg of ranitidine U FEB / 07
Rasagiline and its saltsF1 I APR / 08
RasburicaseF1 I APR / 07
Raubasine and its saltsF1 I SEP / 98
RauwolfiaF1 I SEP / 98
RemifentanilN I JUN / 02
Remoxipride and its saltsF1 I SEP / 98
Repaglinide and its salts and derivativesF1 I MAY / 00
Rescinnamine and its saltsF1 I SEP / 98
Reserpine and its saltsF2 I SEP / 98
ReslizumabPDL I JUN / 17
Resocortol and its derivatives.FR AUG / 06
Resocortol and its derivatives..F1 I OCT / 07
RetapamulinF1 I OCT / 09
Reviparin and its saltsF1 I SEP / 98
Rho D immune globulin I FEB / 02
RibavirinF1 I SEP / 98
Rifabutin and its saltsF1 I SEP / 98
Rifampin and its salts and derivativesF1 I SEP / 98
Rilpivirine or its salts or derivativesPDL

including but not limited to rilpivirine hydrochloride

I DEC / 13
Riluzole and its saltsF1 I DEC / 02
Risedronic acid and its saltsF1 I MAR / 01
Risperidone and its saltsF1 I SEP / 98
Ritodrine and its saltsF1 I SEP / 98
RitonavirF1 I SEP / 98
RituximabF1 I DEC / 01
RivaroxabanF1 I MAY / 10
Rivastigmine and its saltsF1 I SEP / 99
Rocuronium bromideF1 I SEP / 98
RofecoxibF1 I MAR / 01
Roflumilast or its salts or derivativesPDL I DEC / 13
Romifidine and its saltsF1 I MAY / 04
RomiplostimF1 I MAR / 11
Ronidazole and its salts and derivativesF2 I SEP / 98
Ropinirole and its saltsF1 I SEP / 98
Rose Bengal II SEP / 98
Rosiglitazone and its saltsF1 I DEC / 01
Rosoxacin and its saltsF1 I SEP / 98
Rosuvastatin and its saltsF1 I JUN / 06
Rubella vaccine II DEC / 98
Rue and its preparations and extracts II SEP / 98
Rufinamide or its derivativesPDL I DEC / 13
RupatadinePDL I FEB / 17

58 result(s)


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations}
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drus Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled